Article Information
History
- November 10, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Anna Schultze1,*,
- Ivonne Martin2,
- Davide Messina3,
- Sophie Bots4,
- Svetlana Belitser4,
- Juan José Carreras-Martínez5,6,
- Elisa Correcher-Martinez5,6,
- Arantxa Urchueguía-Fornes5,6,
- Mar Martín-Pérez7,
- Patricia García-Poza7,
- Felipe Villalobos8,
- Meritxell Pallejà-Millán8,
- Carlo Alberto Bissacco8,
- Elena Segundo8,
- Patrick Souverein4,
- Fabio Riefolo9,
- Carlos E. Durán2,
- Rosa Gini3,
- Miriam Sturkenboom2,
- Olaf Klungel4 and
- Ian Douglas1
- 1Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, United Kingdom
- 2Department Data Science & Biostatistics, University Medical Centre Utrecht, the Netherlands
- 3Agenzia Regionale di Sanità (ARS), Italy
- 4Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands
- 5Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)
- 6CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III
- 7Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain
- 8Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
- 9Teamit Institute, Partnerships, Barcelona Health Hub, Barcelona, Spain
- ↵*Corresponding author; email: anna.schultze{at}lshtm.ac.uk
Posted November 10, 2023.
A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and Myocarditis using Five European Databases
